REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/17/2026
Back to search
Official data from USPTO
BOSTONGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BOSTONGENE
ST13
US500000090089889Class
42, 44
Filing
90089889
Registration
6457963
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/17/2026
Trademark type
Word
Nice classes
42, 44
Filing date
08/03/2020
Registration date
08/17/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2021
Last transaction
08/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2020-04-00
First use in commerce
2020-04-00
Drawing code
4
Owner type
03
Owner location
Waltham, MA, US
Examiner
WATTS-FITZGERALD, CAITLIN C
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
B. C. (pessoa física)
Representatives
Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics; medical laboratory services being medical researchin the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; providing temporary use of onlinenon-downloadable software for genetic assessment and identification of cancerdiseaseshealth status and metricsgene mutations for scientificmedicaldiagnostictreatmentresearch purposes; providing temporary use of onlinenon-downloadable software used for the sequencing and analyses of genomicproteomictranscriptomic data; providing temporary use of onlinenon-downloadable software used to integrate and create data models; software as a service (SAAS) services featuring software for analyzing and visualizing genomicproteomictranscriptomic dataevaluating health status and diagnosing diseasesdisorderssyndromes; software as a service (SAAS) services featuring software for data managementfor electronic storage of data in the field of clinical trials and electronic health records; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing onlinenon-downloadable computer software for collectinganalyzingreportingtracking data and information in the fields of geneticsgenomicsproteomicstranscriptomicsbiochemistry; providing onlinenon-downloadable software for use in clinical trial data management and for management of electronic health records
Class 44
Genetic testing for medical purposesspecificallygenomicproteomictranscriptomicmolecular medical testing for cancer and other diagnostic or treatment purposes; Providing medical informationproviding collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; Providing medical informationspecificallyproviding collected and analyzed medical information in the field of genomicsproteomicstranscriptomics for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; providing online computer databases of genomic sequences for medical scientific researchfor medical trackingmatchingsearchingtestingaggregatingresearchingevaluating health statusfor the purpose of diagnosing diseases and gene mutations; providing an online Internet website portal featuring medical informationmedicalgeneticgenomicproteomictranscriptomic information and data in the field of cancer for diagnostic and treatment purposes; providing an online Internet website portal featuring medical informationmedicalgeneticgenomicproteomictranscriptomic information and data for scientificlaboratorymedical research and development purposes
Publications
History of USPTO decisions and trademark events.
24 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
08/17/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/13/2021
ALIE
ASSIGNED TO LIE
07/12/2021
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
07/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/28/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/28/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/28/2021
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
06/25/2021
IUAA
USE AMENDMENT ACCEPTED
06/24/2021
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
06/09/2021
IUAF
USE AMENDMENT FILED
06/09/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
06/08/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/12/2021
GNRT
NON-FINAL ACTION E-MAILED
03/12/2021
CNRT
NON-FINAL ACTION WRITTEN
03/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/10/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/23/2020
GNRT
NON-FINAL ACTION E-MAILED
11/23/2020
CNRT
NON-FINAL ACTION WRITTEN
11/23/2020
DOCK
ASSIGNED TO EXAMINER
11/23/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/01/2020
Continuous trademark protection
Get notified about every new filing that threatens BOSTONGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.